Literature DB >> 35790445

[Hypoxia promotes differentiation of human induced pluripotent stem cells into embryoid bodies in vitro].

L Fang1, Z Feng2, J Mei3, J Zhou1, Z Lin1.   

Abstract

OBJECTIVE: To investigate effects of physiological hypoxic conditions on suspension and adherence of embryoid bodies (EBs) during differentiation of human induced pluripotent stem cells (hiPSCs) and explore the underlying mechanisms.
METHODS: EBs in suspension culture were divided into normoxic (21% O2) and hypoxic (5% O2) groups, and those in adherent culture were divided into normoxic, hypoxic and hypoxia + HIF-1α inhibitor (echinomycin) groups. After characterization of the pluripotency with immunofluorescence assay, the hiPSCs were digested and suspended under normoxic and hypoxic conditions for 5 days, and the formation and morphological changes of the EBs were observed microscopically; the expressions of the markers genes of the 3 germ layers in the EBs were detected. The EBs were then inoculated into petri dishes for further culture in normoxic and hypoxic conditions for another 2 days, after which the adhesion and peripheral expansion rate of the adherent EBs were observed; the changes in the expressions of HIF-1α, β-catenin and VEGFA were detected in response to hypoxic culture and echinomycin treatment.
RESULTS: The EBs cultured in normoxic and hypoxic conditions were all capable of differentiation into the 3 germ layers. The EBs cultured in hypoxic conditions showed reduced apoptotic debris around them with earlier appearance of cystic EBs and more uniform sizes as compared with those in normoxic culture. Hypoxic culture induced more adherent EBs than normoxic culture (P < 0.05) with also a greater outgrowth rate of the adherent EBs (P < 0.05). The EBs in hypoxic culture showed significantly up-regulated mRNA expressions of β-catenin and VEGFA (P < 0.05) and protein expressions of HIF-1 α, β-catenin and VEGFA (P < 0.05), and their protein expresisons levels were significantly lowered after treatment with echinomycin (P < 0.05).
CONCLUSION: Hypoxia can promote the formation and maturation of suspended EBs and enhance their adherence and post-adherent proliferation without affecting their pluripotency for differentiation into all the 3 germ layers. Our results provide preliminary evidence that activation of HIF-1α/β-catenin/VEGFA signaling pathway can enhance the differentiation potential of hiPSCs.

Entities:  

Keywords:  HIF-1α; differentiation; embryoid body; human-induced pluripotent stem cells; hypoxia

Mesh:

Substances:

Year:  2022        PMID: 35790445      PMCID: PMC9257350          DOI: 10.12122/j.issn.1673-4254.2022.06.18

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  30 in total

1.  Effects of cobalt chloride on the stem cell marker expression and osteogenic differentiation of stem cells from human exfoliated deciduous teeth.

Authors:  Yijing Chen; Qi Zhao; Xin Yang; Xinlin Yu; Dongsheng Yu; Wei Zhao
Journal:  Cell Stress Chaperones       Date:  2019-02-26       Impact factor: 3.667

2.  The effects of spheroid formation of adipose-derived stem cells in a microgravity bioreactor on stemness properties and therapeutic potential.

Authors:  Shichang Zhang; Ping Liu; Li Chen; Yingjie Wang; Zhengguo Wang; Bo Zhang
Journal:  Biomaterials       Date:  2014-12-01       Impact factor: 12.479

3.  Embryo catheter loading and embryo culture techniques: results of a worldwide Web-based survey.

Authors:  Mindy S Christianson; Yulian Zhao; Gon Shoham; Irit Granot; Anat Safran; Ayatallah Khafagy; Milton Leong; Zeev Shoham
Journal:  J Assist Reprod Genet       Date:  2014-06-10       Impact factor: 3.412

4.  Modulation of oxygen tension, acidosis, and cell density is crucial for neural differentiation of human induced pluripotent stem cells.

Authors:  Rina Okada; Kazunari Onodera; Takuji Ito; Manabu Doyu; Hirotaka James Okano; Yohei Okada
Journal:  Neurosci Res       Date:  2020-01-31       Impact factor: 3.304

Review 5.  Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach.

Authors:  Ning-Ning Guo; Li-Ping Liu; Yun-Wen Zheng; Yu-Mei Li
Journal:  World J Stem Cells       Date:  2020-01-26       Impact factor: 5.326

6.  Application of Human Induced Pluripotent Stem Cells in Generating Tissue-Engineered Blood Vessels as Vascular Grafts.

Authors:  Xiaoqiang Cong; Shang-Min Zhang; Luke Batty; Jiesi Luo
Journal:  Stem Cells Dev       Date:  2019-11-26       Impact factor: 3.272

7.  Defining the role of oxygen tension in human neural progenitor fate.

Authors:  Yuan Xie; Jin Zhang; Ying Lin; Xavier Gaeta; Xiangzhi Meng; Dona R R Wisidagama; Jessica Cinkornpumin; Carla M Koehler; Cindy S Malone; Michael A Teitell; William E Lowry
Journal:  Stem Cell Reports       Date:  2014-10-30       Impact factor: 7.765

8.  Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells.

Authors:  Areechun Sotthibundhu; Katya McDonagh; Alexander von Kriegsheim; Amaya Garcia-Munoz; Agnieszka Klawiter; Kerry Thompson; Kapil Dev Chauhan; Janusz Krawczyk; Veronica McInerney; Peter Dockery; Michael J Devine; Tilo Kunath; Frank Barry; Timothy O'Brien; Sanbing Shen
Journal:  Stem Cell Res Ther       Date:  2016-11-15       Impact factor: 6.832

9.  Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions.

Authors:  Catherine E Forristal; Kate L Wright; Neil A Hanley; Richard O C Oreffo; Franchesca D Houghton
Journal:  Reproduction       Date:  2010-01       Impact factor: 3.906

10.  Cattle In Vitro Induced Pluripotent Stem Cells Generated and Maintained in 5 or 20% Oxygen and Different Supplementation.

Authors:  Brendon Willian Bessi; Ramon Cesar Botigelli; Naira Caroline Godoy Pieri; Lucas Simões Machado; Jessica Brunhara Cruz; Pamela de Moraes; Aline Fernanda de Souza; Kaiana Recchia; Gabriela Barbosa; Raquel Vasconcelos Guimarães de Castro; Marcelo Fábio Gouveia Nogueira; Fabiana Fernandes Bressan
Journal:  Cells       Date:  2021-06-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.